Horizon Pharma Pays $145 Million For And Its Rare Eye Disease Drug Post author:Sam Post published:May 7, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like AstraZeneca PLC Hits Milestone With Approval of Potential Bladder Cancer Blockbuster May 1, 2017 Galectin Tanks as NASH Drug Flunks Phase IIb Trial December 4, 2017 FDA Expands Bristol-Myers Squibb’s Opdivo Dosing Schedule March 5, 2018